Arbutus Biopharma Corp (ABUS)

Mar 08, 2025

FY2025 Earnings Forecast for ABUS Issued By Chardan Capital - Defense World

Mar 08, 2025

Mar 07, 2025

Are Arbutus Biopharma Corp’shares a good deal? - US Post News

Mar 07, 2025

Mar 05, 2025

Arbutus Biopharma (NASDAQ:ABUS) Rating Increased to Hold at StockNews.com - Defense World

Mar 05, 2025

Mar 04, 2025

Moderna Faces MRNA Vax Patent Suits In Canada And Beyond - Law360

Mar 04, 2025

Mar 03, 2025

Genevant Sciences and Arbutus Biopharma File International Lawsuits Against Moderna for Patent Infringement of Lipid Nanoparticle Technology - Nasdaq

Mar 03, 2025

Mar 03, 2025

Genevant Sciences and Arbutus Biopharma Initiate - GlobeNewswire

Mar 03, 2025

Mar 03, 2025

Can Arbutus Win Billions? Patent Fight Against Moderna's COVID Vaccine Goes Global - StockTitan

Mar 03, 2025

Feb 28, 2025

Arbutus Biopharma (NASDAQ:ABUS) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat

Feb 28, 2025

Feb 28, 2025

StockNews.com Downgrades Arbutus Biopharma (NASDAQ:ABUS) to Sell - MarketBeat

Feb 28, 2025

Feb 28, 2025

Brokers Issue Forecasts for ABUS FY2029 Earnings - MarketBeat

Feb 28, 2025

Feb 28, 2025

Brokers Set Expectations for ABUS FY2029 Earnings - Defense World

Feb 28, 2025

Feb 27, 2025

Arbutus Biopharma (ABUS) Projected to Post Earnings on Thursday - Defense World

Feb 27, 2025

Feb 26, 2025

Arbutus Biopharma (NASDAQ:ABUS) Lowered to “Sell” Rating by StockNews.com - Defense World

Feb 26, 2025

Feb 26, 2025

Arbutus Biopharma Appoints Lindsay Androski as CEO Amid Leadership Restructuring - MyChesCo

Feb 26, 2025

Feb 25, 2025

Lindsay Androski named CEO of Arbutus - BioCentury

Feb 25, 2025

Feb 25, 2025

Arbutus Biopharma appoints new CEO and reshapes board - Investing.com

Feb 25, 2025

Feb 25, 2025

Arbutus Announces Changes to Board of Directors and Appointment of Lindsay Androski as CEO - The Manila Times

Feb 25, 2025

Feb 24, 2025

Arbutus Biopharma Corp expected to post a loss of 8 cents a shareEarnings Preview - TradingView

Feb 24, 2025

Feb 20, 2025

Will Moderna Stock Drop to $25? 1 Wall Street Analyst Thinks So. - The Motley Fool

Feb 20, 2025

Feb 20, 2025

Arbutus Biopharma's CFO David Hastings sells shares worth $72,826 - MSN

Feb 20, 2025

Feb 12, 2025

The Hidden Gem in Nasdaq’s Under $5 Club: Is Arbutus Biopharma the Next Big Thing? - Jomfruland.net

Feb 12, 2025

Feb 12, 2025

Is Arbutus Biopharma Corp. (ABUS) the Best Nasdaq Stock Under $5 to Buy? - MSN

Feb 12, 2025

Feb 11, 2025

Ebola Virus Vaccine Market May See a Big Move| Arbutus Biopharma, BioCryst Pharmaceuticals - openPR

Feb 11, 2025

Feb 08, 2025

SG Americas Securities LLC Purchases 16,250 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Feb 08, 2025

Feb 06, 2025

Arbutus Biopharma Corp (ABUS) Stock: A Look at the Monthly Trend - The News Heater

Feb 06, 2025

Feb 05, 2025

Arbutus Biopharma's CFO David Hastings sells shares worth $72,826 By Investing.com - Investing.com South Africa

Feb 05, 2025

Feb 05, 2025

Jefferies analysts upgrades a Buy rating for Arbutus Biopharma Corp (ABUS) - Knox Daily

Feb 05, 2025

Feb 05, 2025

Arbutus Biopharma Executives Sell Shares to Cover Tax Obligations - TradingView

Feb 05, 2025

Feb 04, 2025

Arbutus Biopharma Corp (ABUS) expanding its growth trajectory ahead - SETE News

Feb 04, 2025

Feb 03, 2025

Morgan Stanley Reduces Stake in Arbutus Biopharma Corp - GuruFocus.com

Feb 03, 2025

Jan 30, 2025

JPMorgan Chase & Co. Increases Stock Position in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Jan 30, 2025

Jan 27, 2025

Ballentine Partners LLC Acquires New Position in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Jan 27, 2025

Jan 27, 2025

Arbutus Biopharma Corp. to Host Earnings Call - ACCESS Newswire

Jan 27, 2025

Jan 22, 2025

Arbutus Biopharma (NASDAQ:ABUS) Receives “Buy” Rating from HC Wainwright - Defense World

Jan 22, 2025

Jan 21, 2025

Arbutus Biopharma (NASDAQ:ABUS) Receives "Buy" Rating from HC Wainwright - MarketBeat

Jan 21, 2025

Jan 17, 2025

Arbutus Biopharma Sets Sights on Advancing HBV Cure in 2025 - MyChesCo

Jan 17, 2025

Jan 16, 2025

Jim Cramer on Arbutus Biopharma Corporation (ABUS): ‘It Loses Money’ - Insider Monkey

Jan 16, 2025

Jan 15, 2025

Barclays PLC Purchases 223,995 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Jan 15, 2025

Jan 13, 2025

Cramer's Lightning Round: Arbutus Biopharma is 'the ultimate spec' - MSN

Jan 13, 2025

Jan 13, 2025

Arbutus Provides 2025 Corporate and Financial Update - GlobeNewswire

Jan 13, 2025

Jan 11, 2025

Jane Street Group LLC Has $258,000 Holdings in Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Jan 11, 2025

Jan 08, 2025

Principal Financial Group Inc. Sells 12,352 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Jan 08, 2025

Jan 07, 2025

Arbutus Biopharma (NASDAQ:ABUS) Sees Large Volume IncreaseShould You Buy? - MarketBeat

Jan 07, 2025

Jan 07, 2025

Arbutus: Positive Imdusiran Data Leads To Phase 2B Development (NASDAQ:ABUS) - Seeking Alpha

Jan 07, 2025

Dec 31, 2024

Geode Capital Management LLC Buys 135,442 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS) - Defense World

Dec 31, 2024

Dec 31, 2024

Barclays PLC Acquires 223,995 Shares of Arbutus Biopharma Co. (NASDAQ:ABUS) - MarketBeat

Dec 31, 2024